The field of oncology is increasingly dedicated to the advancement of FAPI, including assessment of the specific indications for FAPI PET imaging, development of novel FAPI-based radiotracers, and FAP-targeted radioligand therapy in refractory cancers. Here, FAP is linked to cancer.